JPMorgan

Why did Moody's—a legacy financial institution built on risk assessment—move aggressively to adopt generative AI, an unproven technology? Because leadership calculated that the risk of standing still outweighed the risk of moving fast.

From data exposure to hindered skills development, poorly supervised AI use can put companies at considerable risk.

Johnson & Johnson signed a multibillion-dollar contract with ChemImage in 2019. The two companies will face off in court next week.

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases offering training for it.

The industry increased its hiring of governance and ethical use professionals last year, according to Evident Insights.

From boosting corporate sales at MUFG to giving Bridgewater tools to build an AI investment analyst, here's how AWS is helping finance giants with AI.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, top-rated podcasts, and non-profit The Motley Fool Foundation.

The US is going all-in on AI, with spending projected to hit a massive $120 billion by the end of 2025, a 26% annual gro